Coya Therapeutics (COYA) Other financing activities (2022 - 2025)
Coya Therapeutics (COYA) posted Other financing activities of $19137.0 for Q3 2025, little changed sequentially from $19137.0 in Q1 2025, and up 101.27% YoY from $9508.2 in Q3 2024.
Coya Therapeutics (COYA) Other financing activities (2022 - 2025) Analysis & Trends
Coya Therapeutics has reported Other financing activities for 4 years, with the latest figure at $19137.0 in Q3 2025.
- Quarterly Other financing activities rose 101.27% year-over-year to $19137.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $38274.0 (up 1837.92% YoY) and the FY2025 annual result came in at $38274.0, up 1837.92% from the prior year.
- Other financing activities steadied at $19137.0 in Q3 2025 per COYA's latest filing, from $19137.0 in the prior quarter.
- Over five years, Other financing activities peaked at $14.3 million in Q1 2023 and troughed at -$1.5 million in Q3 2024.
- A 4-year average of $2.0 million and a median of $19137.0 in 2025 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2023 and 2024: Other financing activities surged 9019084.18% in 2023, then sank 99.99% in 2024.
- Over 4 years, Other financing activities stood at $158.0 in 2022, then soared by 9019084.18% to $14.3 million in 2023, then sank by 110.58% to -$1.5 million in 2024, then surged by 101.27% to $19137.0 in 2025.
- According to Business Quant data, Other financing activities over the past three periods registered $19137.0, $19137.0, and -$1.5 million for Q3 2025, Q1 2025, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Coya Therapeutics | 113.53 Mn | 70.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 19,137.00 |
| Sep 30, 2025 | 19,137.00 |
| Mar 31, 2025 | 19,137.00 |
| Mar 31, 2025 | 19,137.00 |
| Sep 30, 2024 | -1.51 Mn |
| Sep 30, 2024 | -1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1,975.00 |
| Mar 31, 2024 | 1,975.00 |
| Mar 31, 2023 | 14.25 Mn |
| Mar 31, 2023 | 14.25 Mn |
| Mar 31, 2022 | 158.00 |
| Mar 31, 2022 | 158.00 |